ClinicalTrials.Veeva

Menu

Comparing the Efficacy Between Lignocaine Given Via MADgic Atomizer and Lignocaine Pump Spray

U

Universiti Sains Malaysia

Status

Completed

Conditions

Hemodynamic Instability
Hoarseness
Cough
Sore Throat

Treatments

Device: Lignocaine pump spray
Device: MADgic Atomizer

Study type

Interventional

Funder types

Other

Identifiers

NCT06213116
USM/JEPeM/21080580

Details and patient eligibility

About

Comparing the efficacy between Lignocaine given via MADgic Atomizer and Lignocaine Pump Spray pre endotracheal intubation in adult undergoing General Anesthesia.

Full description

Comparing the efficacy of Lignocaine given via 2 device (Lignocaine Spray and MADGIC Atomizer) on hemodinamic parameters postintubations and severity grading of post operative sore throat, cough and hoarseness of voice.

Enrollment

125 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult with the age of 18 to 65 years old
  • Gender of both male and female
  • Planned for elective surgery scheduled at General Operation Theatre that require elective intubation for general anesthesia
  • American Society Anaesthesiologist (ASA) preoperative physical status assessment of 1 and 2
  • Airway assessment Malampati scoring 1and 2.

Exclusion criteria

  • Pregnancy
  • Known allergy or hypersensitivity to Lignocaine
  • Pre existing sore throat or hoarseness of voice identified during preoperative assessment.
  • The use of airway device other than endotracheal tube (ETT) such Laryngeal Mask airway/Supraglottic Device'
  • Oral and neck surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

125 participants in 2 patient groups

MADgic Atomizer
Experimental group
Description:
Group M(MADgic) acting as Intervention Group: Patients receiving Lignocaine 30mg (3 alliquotes) given via MADgic Laryngotracheal Atomization Device prior to endotracheal intubation.
Treatment:
Device: MADgic Atomizer
Lignocaine Spray
Active Comparator group
Description:
Group S (Spray) acting as Control Group: Patients receiving Lignocaine 30 mg (3 puffs) given via 10mg Lignocain Pump Spray prior to endotracheal intubation.
Treatment:
Device: Lignocaine pump spray

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems